A. R. Ermolaev
Research Subjects
A. R. Ermolaev has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Albina A. Ivanova
M.K. Ammosov North-Eastern Federal University
1 shared publication - L. E. Davydova
GBU RS (Y) «Blood Transfusion Station
1 shared publication - Nadezhda Chulakova
M.K. Ammosov North-Eastern Federal University; Yakut Republic Clinical Hospital
1 shared publication - Valentina Gerasimova
North-Eastern Federal University named after M.K. Ammosov
1 shared publication
Latest Publications
- 30 December 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 88-91
Detection of antibodies to the nuclear antigen of hepatitis B virus in donors from Yakutia as a method of enhancing viral safety
Identifying donors with latent infection and a history of viral hepatitis, followed by their exclusion from donation, is one method for harvesting virus-safe blood components and, consequently, minimizing the risk of post-transfusion complications. To this end, an analysis of the results of a study on antibodies to the hepatitis B core antigen (anti-HBcore) was conducted in donors at the Sakha Republic (Yakutia) Blood Transfusion Center in 2021-2024. During the entire study period the overall detection rate of anti-HBcore was 26.3%, with no statistically significant gender-based difference (25.3% in men vs. 28.2% in women; p = 0.912). Donor age appeared to be one of the main factors influencing anti-HBcore prevalence: the lowest frequency of anti-HBcore was observed in the 21-30 age group – 3.8%, in the 41-50 age group – 58.8%, and in the group over 50 years – 41.0%. Based on the analysis of the obtained results, it is proposed to determine anti-HBcore with each donation for donors over 30-35 years of age.
- 30 December 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 88-91
Detection of antibodies to the nuclear antigen of hepatitis B virus in donors from Yakutia as a method of enhancing viral safety
Identifying donors with latent infection and a history of viral hepatitis, followed by their exclusion from donation, is one method for harvesting virus-safe blood components and, consequently, minimizing the risk of post-transfusion complications. To this end, an analysis of the results of a study on antibodies to the hepatitis B core antigen (anti-HBcore) was conducted in donors at the Sakha Republic (Yakutia) Blood Transfusion Center in 2021-2024. During the entire study period the overall detection rate of anti-HBcore was 26.3%, with no statistically significant gender-based difference (25.3% in men vs. 28.2% in women; p = 0.912). Donor age appeared to be one of the main factors influencing anti-HBcore prevalence: the lowest frequency of anti-HBcore was observed in the 21-30 age group – 3.8%, in the 41-50 age group – 58.8%, and in the group over 50 years – 41.0%. Based on the analysis of the obtained results, it is proposed to determine anti-HBcore with each donation for donors over 30-35 years of age.